Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SILGAN HOLDINGS INCSLGN · Entity 3995 | Director | February 22, 2019 | February 22, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SILGAN HOLDINGS INC
Report date February 22, 2019 · Filed February 22, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 39,053 |
Reported balance
After 2019-02-22 transaction · row 1
1 source rowRow 1 · 2019-02-22 · Sale · Disposed 6,362 · Balance 39,053 F1: The range of sales prices for 02/22/2019 was $28.80 - $28.837. The reporting person undertakes to provide, upon the request of the SEC staff, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
Filing footnotes · ownership attribution and instrument terms
F1: The range of sales prices for 02/22/2019 was $28.80 - $28.837. The reporting person undertakes to provide, upon the request of the SEC staff, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
SPECTRANETICS CORP
Report date August 09, 2017 · Filed August 11, 2017
Section 16 reporting ended · disclosed 2017-08-11. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| SPNC Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-08-09 transaction · row 1
1 source rowRow 1 · 2017-08-09 · Disposition to issuer · Disposed 69,493 · Balance 0 F1: Per the terms of the Agreement and Plan of Merger, dated as of June 27, 2017, among the Company, Philips Holding USA Inc., a Delaware corporation, and HealthTech Merger Sub, Inc., a Delaware corporation (the "Merger Agreement") and the Offer (as defined in the Merger Agreement), each share of Company common stock other than the restricted common stock described in Note 2 was validly tendered for $38.50 per share in cash, without interest and less any required withholding taxes. F2: Includes 4,780 shares of restricted common stock that, pursuant to their terms upon consummation of the Merger Agreement, were canceled at the Effective Time (as defined in the Merger Agreement) and converted into the right to receive $38.50 per share in cash, without interest. |
Filing footnotes · ownership attribution and instrument terms
F1: Per the terms of the Agreement and Plan of Merger, dated as of June 27, 2017, among the Company, Philips Holding USA Inc., a Delaware corporation, and HealthTech Merger Sub, Inc., a Delaware corporation (the "Merger Agreement") and the Offer (as defined in the Merger Agreement), each share of Company common stock other than the restricted common stock described in Note 2 was validly tendered for $38.50 per share in cash, without interest and less any required withholding taxes.
F2: Includes 4,780 shares of restricted common stock that, pursuant to their terms upon consummation of the Merger Agreement, were canceled at the Effective Time (as defined in the Merger Agreement) and converted into the right to receive $38.50 per share in cash, without interest.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 22, 2019 Filed Feb 22, 2019 22:05 UTC | SILGAN HOLDINGS INC SLGN · Entity 3995 | SaleCommon Stock | 6,362 | $28.81 | $183,291.13 |
DisclosureSEC source: 0001567619-19-005275 · doc1.xml · nonDerivative · entry 1 JENNINGS WILLIAM C · CIK 0001276559 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,053 F1 · price: The range of sales prices for 02/22/2019 was $28.80 - $28.837. The reporting person undertakes to provide, upon the request of the SEC staff, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 12, 2018 Filed Jun 14, 2018 20:45 UTC | SILGAN HOLDINGS INC SLGN · Entity 3995 | GrantCommon Stock | 3,235 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-18-028625 · doc1.xml · nonDerivative · entry 1 JENNINGS WILLIAM C · CIK 0001276559 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,415 F1 · price: These securities are restricted stock units that were granted on June 12, 2018 pursuant to the Silgan Holdings Inc. Amended and Restated 2004 Stock Incentive Plan and become fully vested on June 12, 2019. These restricted stock units will be settled in shares of Common Stock on a 1-for-1 basis upon vesting. Read SEC document |
| November 28, 2017 Filed Nov 30, 2017 21:46 UTC | SILGAN HOLDINGS INC SLGN · Entity 3995 | SaleCommon Stock | 25,642 | $28.38 | $727,719.96 |
DisclosureSEC source: 0001140361-17-044466 · doc1.xml · nonDerivative · entry 1 JENNINGS WILLIAM C · CIK 0001276559 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,180 F1 · price: The range of sales prices for 11/28/2017 was $28.28 - $28.46. The reporting person undertakes to provide, upon the request of the SEC staff, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 09, 2017 Filed Aug 11, 2017 14:34 UTC | SPECTRANETICS CORP SPNC · Entity 173862 | Disposition to issuerSPNC Common Stock | 69,493 | $38.50 | $2,675,480.50 |
DisclosureSEC source: 0001179110-17-011361 · edgar.xml · nonDerivative · entry 1 JENNINGS WILLIAM C · CIK 0001276559 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Per the terms of the Agreement and Plan of Merger, dated as of June 27, 2017, among the Company, Philips Holding USA Inc., a Delaware corporation, and HealthTech Merger Sub, Inc., a Delaware corporation (the "Merger Agreement") and the Offer (as defined in the Merger Agreement), each share of Company common stock other than the restricted common stock described in Note 2 was validly tendered for $38.50 per share in cash, without interest and less any required withholding taxes. F2 · shares: Includes 4,780 shares of restricted common stock that, pursuant to their terms upon consummation of the Merger Agreement, were canceled at the Effective Time (as defined in the Merger Agreement) and converted into the right to receive $38.50 per share in cash, without interest. Read SEC document |
| June 08, 2017 Filed Jun 12, 2017 17:26 UTC | SPECTRANETICS CORP SPNC · Entity 173862 | GrantSPNC Common Stock | 4,780 | $0.00 | $0.00 |
DisclosureSEC source: 0000789132-17-000097 · wf-form4_149730276448417.xml · nonDerivative · entry 1 JENNINGS WILLIAM C · CIK 0001276559 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,493 F1 · shares: Director compensation grant of SPNC restricted stock, vesting over 1 year, 100% vested on 6/8/2018. Read SEC document |
| June 06, 2017 Filed Jun 8, 2017 20:08 UTC | SILGAN HOLDINGS INC SLGN · Entity 3995 | GrantCommon Stock | 2,854 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-17-024467 · doc1.xml · nonDerivative · entry 1 JENNINGS WILLIAM C · CIK 0001276559 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,822 F1 · price: These securities are restricted stock units that were granted on June 6, 2017 pursuant to the Silgan Holdings Inc. Amended and Restated 2004 Stock Incentive Plan and become fully vested on June 6, 2018. These restricted stock units will be settled in shares of Common Stock on a 1-for-1 basis upon vesting. F2 · balance_after: On May 26, 2017, a two-for-one stock split of the Common Stock of Silgan Holdings Inc. in the form of a stock dividend was effected, resulting in the reporting person's direct ownership of 32,484 additional shares of Common Stock of Silgan Holdings Inc. on such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.